Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study.

Acuity Contrast sensitivity Diabetic retinopathy Low-luminance acuity Machine learning Microperimetry Perimetry Statistics Visual function

Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
12 2023
Historique:
received: 20 03 2023
accepted: 14 07 2023
medline: 7 11 2023
pubmed: 19 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

To determine the extent to which diabetic retinopathy severity stage may be classified using machine learning (ML) and commonly used clinical measures of visual function together with age and sex. We measured the visual function of 1901 eyes from 1032 participants in the Northern Ireland Sensory Ageing Study, deriving 12 variables from nine visual function tests. Missing values were imputed using chained equations. Participants were divided into four groups using clinical measures and grading of ophthalmic images: no diabetes mellitus (no DM), diabetes but no diabetic retinopathy (DM no DR), diabetic retinopathy without diabetic macular oedema (DR no DMO) and diabetic retinopathy with DMO (DR with DMO). Ensemble ML models were fitted to classify group membership for three tasks, distinguishing (A) the DM no DR group from the no DM group; (B) the DR no DMO group from the DM no DR group; and (C) the DR with DMO group from the DR no DMO group. More conventional multiple logistic regression models were also fitted for comparison. An interpretable ML technique was used to rank the contribution of visual function variables to predictions and to disentangle associations between diabetic eye disease and visual function from artefacts of the data collection process. The performance of the ensemble ML models was good across all three classification tasks, with accuracies of 0.92, 1.00 and 0.84, respectively, for tasks A-C, substantially exceeding the accuracies for logistic regression (0.84, 0.61 and 0.80, respectively). Reading index was highly ranked for tasks A and B, whereas near visual acuity and Moorfields chart acuity were important for task C. Microperimetry variables ranked highly for all three tasks, but this was partly due to a data artefact (a large proportion of missing values). Ensemble ML models predicted status of diabetic eye disease with high accuracy using just age, sex and measures of visual function. Interpretable ML methods enabled us to identify profiles of visual function associated with different stages of diabetic eye disease, and to disentangle associations from artefacts of the data collection process. Together, these two techniques have great potential for developing prediction models using untidy real-world clinical data.

Identifiants

pubmed: 37725107
doi: 10.1007/s00125-023-06005-3
pii: 10.1007/s00125-023-06005-3
pmc: PMC10627908
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2250-2260

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Ophthalmic Physiol Opt. 2011 Jan;31(1):17-22
pubmed: 21158882
Ann Med. 2022 Dec;54(1):1816-1825
pubmed: 35786137
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO277-BIO290
pubmed: 28973314
Invest Ophthalmol Vis Sci. 2013 Nov 11;54(12):7378-85
pubmed: 24135753
Acta Diabetol. 2017 Jun;54(6):515-525
pubmed: 28224275
Ophthalmology. 2021 Nov;128(11):1580-1591
pubmed: 33940045
Acta Ophthalmol. 2020 Mar;98(2):e224-e231
pubmed: 31517447
Int J Epidemiol. 2023 Aug 2;52(4):1276-1285
pubmed: 36905602
Eur J Epidemiol. 2018 May;33(5):459-464
pubmed: 29637384
Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):35
pubmed: 33760040
Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3393-8
pubmed: 12407148
Ophthalmology. 2008 Sep;115(9):1480-8, 1488.e1-2
pubmed: 18486216
Clin Exp Ophthalmol. 2012 May-Jun;40(4):369-80
pubmed: 22339936
NPJ Digit Med. 2023 Jan 24;6(1):7
pubmed: 36690689
Curr Diab Rep. 2019 Feb 26;19(4):17
pubmed: 30806815
Curr Eye Res. 2020 Aug;45(8):975-985
pubmed: 31847599
Lancet Diabetes Endocrinol. 2020 Apr;8(4):337-347
pubmed: 32113513
Ophthalmic Physiol Opt. 2010 Sep;30(5):705-16
pubmed: 20883358
Ophthalmology. 2013 Apr;120(4):844-51
pubmed: 23332590
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3625-3635
pubmed: 34264395
NPJ Digit Med. 2020 Mar 26;3:47
pubmed: 32258429
Diabetologia. 2018 Sep;61(9):1902-1912
pubmed: 30030554
Health Technol Assess. 2015 Oct;19(78):1-298
pubmed: 26445075
Ophthalmology. 1997 Oct;104(10):1677-91
pubmed: 9331210
Br J Ophthalmol. 2000 Mar;84(3):244-50
pubmed: 10684832
BMC Public Health. 2023 Mar 10;23(1):466
pubmed: 36899371
Am J Optom Physiol Opt. 1980 Jun;57(6):378-87
pubmed: 7406006
J Optom. 2019 Jul - Sep;12(3):174-179
pubmed: 29843983
Diagnostics (Basel). 2021 Dec 24;12(1):
pubmed: 35054207
Ophthalmology. 2015 May;122(5):957-67
pubmed: 25601533
Eye (Lond). 2017 Jun;31(6):931-939
pubmed: 28257130
Transl Vis Sci Technol. 2022 May 2;11(5):4
pubmed: 35511149
Invest Ophthalmol Vis Sci. 1997 Jan;38(1):207-18
pubmed: 9008645

Auteurs

David M Wright (DM)

Centre for Public Health, Queen's University Belfast, Belfast, UK. d.wright@qub.ac.uk.

Usha Chakravarthy (U)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Radha Das (R)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Katie W Graham (KW)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Timos T Naskas (TT)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Jennifer Perais (J)

Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.

Frank Kee (F)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Tunde Peto (T)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Ruth E Hogg (RE)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH